Dietary Phytoestrogens and Bone Metabolism
NCT00010686 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2006-08-18
Summary
The purpose of this study is to determine whether dietary phytoestrogens are an effective alternative to postmenopausal exogenous estrogen replacement therapy in preventing bone loss.
Conditions
Interventions
- DRUG
-
Dietary Phytoestrogens
Sponsors & Collaborators
-
National Center for Complementary and Integrative Health (NCCIH)
lead NIH
Principal Investigators
-
Dr. John P. Bilezikian · Columbia University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 50 Years
- Max Age
- 72 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Completion
- 2005-12-31
Countries
- United States
Study Locations
More Related Trials
-
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
NCT00000430 ·Status: TERMINATED ·Phase: PHASE3
-
Bone Response to Soy Isoflavones in Women
NCT00043745 ·Status: COMPLETED ·Phase: PHASE2
-
Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa
NCT02475265 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Exemestane on Bone Strength
NCT01144468 ·Status: COMPLETED
-
Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
NCT00693667 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
NCT00004650 ·Status: COMPLETED ·Phase: PHASE3
-
Rhythmic Estradiol and Bone Health
NCT05903820 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density
NCT00715676 ·Status: COMPLETED ·Phase: PHASE2
-
Third Year Evaluation on Genistein Efficacy and Safety
NCT00626769 ·Status: COMPLETED
-
Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause
NCT00290212 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Health in Adolescents and Young Adults With Oral Macro-progestin Treatment
NCT04007614 ·Status: WITHDRAWN
-
Osteoporosis Prevention With Low Dose Alendronate
NCT00463268 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
NCT01753856 ·Status: COMPLETED ·Phase: PHASE4
-
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
NCT00354302 ·Status: COMPLETED ·Phase: PHASE3
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Vitamin K and Bone Turnover in Postmenopausal Women
NCT00062595 ·Status: COMPLETED ·Phase: PHASE3
-
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
NCT00086619 ·Status: COMPLETED ·Phase: PHASE2
-
HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.
NCT00376662 ·Status: COMPLETED ·Phase: PHASE4
-
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
NCT00043069 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
NCT04026256 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa
NCT00320567 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin-Micronutrients for Osteopenia Treatment Study
NCT01870115 ·Status: COMPLETED ·Phase: PHASE1
-
Vitamin K Supplementation in Post-Menopausal Osteopenia
NCT00150969 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Anabolic Osteoporosis Therapy
NCT05688969 ·Status: RECRUITING ·Phase: NA
-
Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women
NCT00372099 ·Status: COMPLETED ·Phase: PHASE3